ESSA Pharma
EPIX
EPIX
37 hedge funds and large institutions have $98.3M invested in ESSA Pharma in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 13 closing their positions.
Holders
37
Holders Change
-8
Holders Change %
-17.78%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
8
Closed
13
Calls
$549K
Puts
$477K
Net Calls
+$72K
Net Calls Change
+$179K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$9.22M |
| 2 |
O
2
OrbiMed
New York
|
$3.56M |
| 3 |
PHS
3
PFM Health Sciences
San Francisco,
California
|
$12.4M |
| 4 |
SCM
4
Soleus Capital Management
Greenwich,
Connecticut
|
$12.3M |
| 5 |
5
Millennium Management
New York
|
$1.25M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
51
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
52
Citadel Advisors
Miami,
Florida
| – | – | – | – |
|
53
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $0 | 48 | +48 | New |
|